Related references
Note: Only part of the references are listed.The β3-adrenoceptor as a therapeutic target: Current perspectives
Maria Grazia Ursino et al.
PHARMACOLOGICAL RESEARCH (2009)
Structural basis for ligand binding and specificity in adrenergic receptors: Implications for GPCR-targeted drug discovery
Thomas Huber et al.
BIOCHEMISTRY (2008)
Stereospecific synthesis and bio-activity of novel β3-adrenoceptor agonists and inverse agonists
Maria Grazia Perrone et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2008)
Therapeutic targets for urinary incontinence
L. A. Sorbera et al.
DRUGS OF THE FUTURE (2008)
Antiarrhythmic effects of beta3-adrenergic receptor stimulation in a canine model of ventricular tachycardia
Shengmei Zhou et al.
HEART RHYTHM (2008)
The discovery of drugs for obesity, the metabolic effects of leptin and variable receptor pharmacology:: perspectives from β3-adrenoceptor agonists
Jonathan R. S. Arch
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2008)
Upregulation of beta(3)-Adrenergic Receptor mRNA in Human Colon Cancer: A Preliminary Study
Maria Grazia Perrone et al.
ONCOLOGY (2008)
Confirmation of antidepressant potential of the selective β3 adrenoceptor agonist amibegron in an animal model of depression
David H. Overstreet et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2008)
In vitro and in vivo pharmacological characterization of ethyl-4-{trans-4-[((2S)-2-hydroxy-3-{(methylsulfonyl)amino]-phenoxy}propyl) amino]cyclohexyl}benzoate hydrochloride (SAR150640), a new potent and selective human β3-adrenoceptor agonist for treatment of preterm labor
Tiziano Croci et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2007)
The norepinephrine-driven metastasis development of PC-3 human prostate cancer cells in BALB/c nude mice is inhibited by β-blockers
D Palm et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
A chemoenzymatic scalable route to optically active (R)-1-(pyridin-3-yl)-2-aminoethanol, valuable moiety of β3-adrenergic receptor agonists
MG Perrone et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2006)
beta(3)-Adrenoceptors in the cardiovascular system: Putative roles in human pathologies
Bertrand Rozec et al.
PHARMACOLOGY & THERAPEUTICS (2006)
Recent developments in the design of orally bioavailable beta(3)-adrenergic receptor agonists
M Sawa et al.
CURRENT MEDICINAL CHEMISTRY (2006)
Characterization of β3-adrenergic receptor:: determination of pharmacophore and 3D QSAR model for β3 adrenergic receptor agonism
P Prathipati et al.
JOURNAL OF COMPUTER-AIDED MOLECULAR DESIGN (2005)
Comparative pharmacology of human β-adrenergic receptor subtypes -: characterization of stably transfected receptors in CHO cells
C Hoffmann et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2004)
Corrected emission spectra and quantum yields for a series of fluorescent compounds in the visible spectral region
RA Velapoldi et al.
JOURNAL OF FLUORESCENCE (2004)
Cyclic amine sulfonamides as linkers in the design and synthesis of novel human β3 adrenergic receptor agonists
FW Sum et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2003)
Novel and potent human and rat β3-adrenergic receptor agonists containing substituted 3-indolylalkylamines
H Harada et al.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS (2003)
A practical approach to the synthesis of 2,4-disubstituted oxazoles from amino acids
T Morwick et al.
ORGANIC LETTERS (2002)
Synthesis and evaluation of potent and selective β3 adrenergic receptor agonists containing acylsulfonamide, sulfonylsulfonamide, and sulfonylurea carboxylic acid isosteres
DE Uehling et al.
JOURNAL OF MEDICINAL CHEMISTRY (2002)
Beta3-adrenoceptor agonists as anti-diabetic and anti-obesity drugs in humans
CJ de Souza et al.
CURRENT PHARMACEUTICAL DESIGN (2001)
Molecular and pharmacokinetic properties of 222 commercially available oral drugs in humans
T Sakaeda et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2001)
Functional assessment of beta adrenoceptor subtypes in human colonic circular and longitudinal (taenia coli) smooth muscle
L Manara et al.
GUT (2000)
Share Paper
